FDA Inspection
Christopher P. Recknor MDChristopher P. Recknor MD – FDA Inspection, May 1, 2017
Record Details
This FDA Inspection record concerns Christopher P. Recknor MD, with an inspection on May 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4071e8e6-2ad9-4464-994f-8977a653d509
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1016324
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 50.27(a)Consent form not approved/signed/dated
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Christopher P. Recknor MD
3| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 18, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 16, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Christopher P. Recknor MD
- FDA Inspection 1173805 - 2022-06-10
- FDA Inspection 1098785 - 2019-07-18
- FDA Inspection 995255 - 2016-12-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.